Literature DB >> 26498178

Placental characteristics in women with polycystic ovary syndrome.

Maria P H Koster1, Marlieke A de Wilde2, Susanne M Veltman-Verhulst2, Michiel L Houben3, Peter G J Nikkels4, Bas B van Rijn5, Bart C J M Fauser2.   

Abstract

STUDY QUESTION: Are macroscopic and microscopic placental characteristics in a heterogeneous group of women diagnosed with polycystic ovary syndrome (PCOS) different from those of a low-risk general population? SUMMARY ANSWER: Women with PCOS have significantly different microscopic placental characteristics compared with control women, independently from pregnancy complications. WHAT IS KNOWN ALREADY: Non-obese women with PCOS who conceived spontaneously have a significantly reduced placental volume and weight, with more chronic villitis and intervillositis compared with healthy controls. STUDY DESIGN, SIZE, DURATION: A subset of a large prospective cohort study of pregnant women with PCOS was used. Healthy (low-risk) women who delivered at term after an uncomplicated pregnancy were used as the reference population. The placentas of 73 women with PCOS were analysed and compared with 209 placentas of healthy women. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Placentas were collected after delivery from women with PCOS who were followed from prior to conception until delivery. The placentas were macroscopically and microscopically analysed and compared with placentas of healthy women with either a spontaneous start of labour who delivered at term or who had an elective Caesarean section. MAIN RESULTS AND THE ROLE OF CHANCE: After adjusting for potential confounders, placentas from women with PCOS showed more chorioamnionitis (P < 0.001), funisitis (P = 0.019), villitis (P = 0.045), thrombosis (P = 0.018), infarction (P = 0.010), villous immaturity (P = 0.009) and nucleated fetal red blood cells (P < 0.001). In a subgroup analysis, among women with and without pregnancy complications within the PCOS group, only the occurrence of thrombosis was increased in pregnancies complicated by pregnancy-induced hypertension or pre-eclampsia (30%, versus 0% in gestational diabetes pregnancies and 13% in uncomplicated pregnancies; P = 0.008). LIMITATIONS, REASONS FOR CAUTION: There might be a small proportion of women with PCOS in the reference group, since this group was not screened for PCOS. As a result, the observed difference may be an underestimation of the true difference. Placentas were stored for up to 72 h at 4°C, this is common practice but some degenerative changes cannot be ruled out absolutely. Also, there is possibility that baseline differences between the groups may in part explain some of the differences in placental pathology. WIDER IMPLICATIONS OF THE
FINDINGS: Our findings suggest that, in general, women with PCOS can have placental alterations associated with an increased hypoxic state, which seems not to be caused by the increased incidence of pregnancy complications.
© The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  histology; microscopic; placenta; polycystic ovary syndrome; pregnancy complications

Mesh:

Year:  2015        PMID: 26498178     DOI: 10.1093/humrep/dev265

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  13 in total

Review 1.  A Narrative Review of Placental Contribution to Adverse Pregnancy Outcomes in Women With Polycystic Ovary Syndrome.

Authors:  Angela S Kelley; Yolanda R Smith; Vasantha Padmanabhan
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

2.  Prenatal Testosterone Excess Disrupts Placental Function in a Sheep Model of Polycystic Ovary Syndrome.

Authors:  Angela S Kelley; Muraly Puttabyatappa; Joseph N Ciarelli; Lixia Zeng; Yolanda R Smith; Richard Lieberman; Subramaniam Pennathur; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2019-11-01       Impact factor: 4.736

3.  Association of PCOS with offspring morbidity: a longitudinal cohort study.

Authors:  Shu Qin Wei; Marianne Bilodeau-Bertrand; Nathalie Auger
Journal:  Hum Reprod       Date:  2022-08-25       Impact factor: 6.353

Review 4.  Mechanisms of intergenerational transmission of polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Luis R Hoyos; Gregorio D Chazenbalk; Rajanigandha Naik; Vasantha Padmanabhan; David H Abbott
Journal:  Reproduction       Date:  2020-01       Impact factor: 3.906

Review 5.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

Review 6.  Secretory products of the corpus luteum and preeclampsia.

Authors:  María M Pereira; Monica Mainigi; Jerome F Strauss
Journal:  Hum Reprod Update       Date:  2021-06-22       Impact factor: 15.610

7.  Does a compromised placenta contribute to transgenerational transmission of metabolic dysfunction in polycystic ovary syndrome?

Authors:  David H Abbott
Journal:  Fertil Steril       Date:  2020-05-06       Impact factor: 7.490

Review 8.  Association between polycystic ovary syndrome and the risk of pregnancy complications: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Hai-Feng Yu; Hong-Su Chen; Da-Pang Rao; Jian Gong
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

9.  Molecular mechanisms underlying altered neurobehavioural development of female offspring of mothers with polycystic ovary syndrome: FOS-mediated regulation of neurotrophins in placenta.

Authors:  Fangfang Wang; Ningning Xie; Jue Zhou; Minchen Dai; Qing Zhang; Paul J Hardiman; Fan Qu
Journal:  EBioMedicine       Date:  2020-09-16       Impact factor: 8.143

Review 10.  Naturally Occurring and Experimentally Induced Rhesus Macaque Models for Polycystic Ovary Syndrome: Translational Gateways to Clinical Application.

Authors:  David H Abbott; Jeffrey Rogers; Daniel A Dumesic; Jon E Levine
Journal:  Med Sci (Basel)       Date:  2019-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.